Michael P. Kelly, President, Global Markets at HAEMONETICS CORP (HAE), sold 1,400 shares at $42.17 ($59K) on 2013-06-14, disclosed to the SEC on 2013-06-18.
Scheduled sale ($59k) by President, Global Markets under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FALC | BUY | 2014-12-16 | $26K | — | Filing → |
| HAE | SELL | 2013-11-13 | $2.4M | — | Filing → |
| HAE | SELL | 2013-10-15 | $57K | — | Filing → |